Saint Louis University School of Law

Scholarship Commons
All Faculty Scholarship
2020

Substance Use Disorder, Discrimination, and The CARES Act:
Using Disability Law to Strengthen New Protections
Kelly K. Dineen
Elizabeth Pendo

Follow this and additional works at: https://scholarship.law.slu.edu/faculty
Part of the Health Law and Policy Commons, Infectious Disease Commons, Legislation Commons,
Respiratory Tract Diseases Commons, and the Virus Diseases Commons

Substance Use Disorder, Discrimination, and The
CARES Act: Using Disability Law to Strengthen New
Protections
Forthcoming in the Arizona State Law Journal Online, Fall 2020
Saint Louis U. Legal Studies Research Paper No. 2020-24

Kelly K. Dineen
Creighton University School of Law

Elizabeth Pendo
Saint Louis University - School of Law

Date Written: Sept. 11, 2020

Abstract
The COVID-19 pandemic is having devastating consequences for people with substance use
disorders (SUD). SUD is a chronic health condition—like people with other chronic health
conditions, people with SUD experience periods of remission and periods of exacerbation and
relapse. Unlike people with most other chronic conditions, people with SUD who experience a
relapse may face criminal charges and incarceration. They are chronically disadvantaged by
pervasive social stigma, discrimination, and structural inequities. People with SUD are also at
higher risk for both contracting the SARS-CoV-19 virus and experiencing poorer outcomes.
Meanwhile, there are early indications that pandemic conditions have led to new and increased
drug use, and overdose deaths are surging. More than ever, people with SUDs need access to
evidence-based treatment and other services without structural barriers and with civil rights
protections. To that end, a new provision in the Coronavirus Aid, Relief, and Economic
Securities Act (CARES Act) strengthens penalties for the wrongful disclosure of SUD treatment
records as well as addresses discrimination in multiple settings based on the misuse of those
records.
People with SUD reasonably fear negative treatment and discrimination if their condition is
exposed. To address this barrier, federal law strictly protects the confidentiality of SUD
treatment records. These protections have existed for nearly 50 years; however, the stringent
requirements have been blamed for hampered and even deadly treatment decisions by health care
providers who do not have access to SUD treatment records.

Section 3221 of the CARES Act, effective March 2021, enacts the first major statutory changes
to SUD treatment record confidentiality since 1992 and is aimed at improving information
sharing among SUD treatment providers and other health care providers. But increased
information sharing also creates concerns about information misuse and discrimination, and the
possibility of renewed treatment avoidance. To address the tension between the benefits of
information sharing and the possible harms of discrimination after disclosure, Section 3221
strengthens the disclosure penalties to align with HIPAA. It also adds an entirely new
nondiscrimination provision which prohibits discriminatory use by recipients of disclosed SUD
treatment information in areas including health care, employment and receipt of worker’s
compensation, rental or sale of housing, access to courts, and social services and benefits funded
by federal, state, or local governments.
This essay provides the first analysis of the new nondiscrimination protections in Section 3221 of
CARES Act for individuals with SUD using the framework of existing protections against
disability-based discrimination in the Americans with Disabilities Act, Section 504 of the
Rehabilitation Act, Section 1557 of the Patient Protection and Affordable Care Act, and the Fair
Housing Act. We propose that as the new protections of Section 3221 are implemented through
regulations, guidance, and enforcement, they should be understood within the context of existing
disability nondiscrimination laws as well as the specific purpose of Section 3221 to ensure that
discrimination against such people does not continue to serve as a barrier to seeking treatment.
We offer three insights to achieve this goal. First, the new protections should be understood to
include current illegal substance users and should be construed broadly. Second, the scope of
entities covered by the new protections should be interpreted consistently with existing
definitions in laws that prohibit disability-based discrimination in employment, public programs,
services, and activities, health care, and housing. Finally, robust enforcement must be coupled
with educational initiatives about the pervasive discrimination faced by people with SUDs, and
new and existing nondiscrimination requirements that protect them.
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